HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$3.19
Day range
$3.13 - $3.21
Year range
$1.81 - $11.31
Market cap
190.45M USD
Avg Volume
311.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.19M | 48.29% |
Net income | -16.50M | -28.22% |
Net profit margin | — | — |
Earnings per share | -0.29 | 9.38% |
EBITDA | -18.47M | -29.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 243.52M | 37.11% |
Total assets | 310.12M | 57.75% |
Total liabilities | 43.15M | 452.38% |
Total equity | 266.97M | — |
Shares outstanding | 60.08M | — |
Price to book | 0.69 | — |
Return on assets | -15.50% | — |
Return on capital | -15.98% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -16.50M | -28.22% |
Cash from operations | -8.31M | 25.79% |
Cash from investing | -48.81M | -139.02% |
Cash from financing | 29.13M | 596.32% |
Net change in cash | -27.99M | -2.00% |
Free cash flow | -4.18M | 41.44% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
51